• Noveris Health Sciences launched a non-brokered private placement of convertible debentures totaling up to $500,000, targeting a close around Aug. 28, 2026.
• Debentures carry 10% annual interest, payable in common shares on conversion, with a 12-month maturity from closing.
• Holders can convert from four months after closing into units at the higher of $0.05 or the 20-day VWAP.
• Each unit includes one common share, one warrant exercisable for 24 months at the higher of $0.05 or the 20-day VWAP.
• Proceeds earmarked for working capital, general and administrative expenses, research and development.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Noveris Health Sciences Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608201814NEWSFILECNPR____20260820_310680_1) on August 20, 2026, and is solely responsible for the information contained therein.